Literature DB >> 5431371

Serum lipoprotein patterns in liver disease.

N M Papadopoulos, M A Charles.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1970        PMID： 5431371     DOI： 10.3181/00379727-134-34886

Source DB:  PubMed          Journal:  Proc Soc Exp Biol Med        ISSN： 0037-9727


× No keyword cloud information.
  7 in total

1.  Plasma alpha-lipoprotein pattern in acute viral hepatitis.

Authors:  N Thalassinos; J Hatzioannou; P Scliros; R Kanaghinis; C Anastasiou; P Crocos; D Thomopoulos; C Gardikas
Journal:  Am J Dig Dis       Date:  1975-02

Review 2.  Abnormalities of Lipoprotein Levels in Liver Cirrhosis: Clinical Relevance.

Authors:  Graziella Privitera; Luisa Spadaro; Simona Marchisello; Giuseppe Fede; Francesco Purrello
Journal:  Dig Dis Sci       Date:  2017-11-25       Impact factor: 3.199

3.  Plasma high-density lipoproteins and hepatic microsomal enzyme induction. Relation to histological changes in the liver.

Authors:  P V Luoma; E A Sotaniemi; R O Pelkonen; A Arranto; C Ehnholm
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

4.  Alterations of rat serum lipoproteins and lecithin-cholesterol-acyltransferase activity in praseodymium-induced liver damage.

Authors:  O Grajewski; B von Lehmann; H R Arntz; P Arvela; E Oberdisse
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1977-12       Impact factor: 3.000

5.  Increased proportion of proapolipoprotein A-I in HDL from patients with liver cirrhosis and hepatitis.

Authors:  T Matsuura; S Koga; H Ibayashi
Journal:  Gastroenterol Jpn       Date:  1988-08

6.  Relationship of alcoholic hypertriglyceridemia to stage of liver disease and dietary lipid.

Authors:  S A Borowsky; W Perlow; E Baraona; C S Lieber
Journal:  Dig Dis Sci       Date:  1980-01       Impact factor: 3.199

7.  An analysis of lipoproteins, bile acids, and red cell membranes associated with target cells and spur cells in patients with liver disease.

Authors:  R A Cooper; M Diloy Puray; P Lando; M S Greenverg
Journal:  J Clin Invest       Date:  1972-12       Impact factor: 14.808
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.